Fresenius Nephrocare Polska sp. z o.o.

Hospital activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-23
Share capital
135,852,000.00 PLN
Activity description

Fresenius Nephrocare Polska is involved in providing chronic and acute kidney dialysis services and therapeutic apheresis. The company offers products and therapies specifically designed for healthcare professionals and patients dealing with chronic kidney disease. Additionally, they engage in research related to hemodiafiltration and its impact on hospitalization for end-stage kidney disease (ESKD).

Registered address
Krzywa 13, 60-118 Poznań, Poland
Email
Social media
Electronic delivery address
AE:PL-16783-60327-ADEGB-28

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$3,549,368

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 87 days for 2021). All were audited by a statutory auditor.

  • 202506/07/2026
  • 202408/07/2025
  • 202310/09/2024
  • 202222/09/2023
  • 202110/10/2022
  • 202014/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Hospital activities10 / 615
Top 1.6%
Division · Human health activities15 / 6,271
Top <1%
City · Poznań48 / 11,701
Top <1%
Voivodeship · Wielkopolskie177 / 30,850
Top <1%
Country · Poland1,429 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 156.93mMedianUSD 3.28mAverageUSD 13.52m
Net profit
This companyUSD 13.77mMedianUSD 60.77kAverageUSD 252.46k
Operating costs
This companyUSD 139.38mMedianUSD 2.99mAverageUSD 12.86m
Assets
This companyUSD 75.73mMedianUSD 2.21mAverageUSD 10.96m

Offer

  • Kidney dialysis
  • Acute dialysis
  • Therapeutic apheresis

Websites

The sites are available in: Polish, English, German, Spanish, Czech and 7 more. The sites target these markets: United Kingdom, United States, Spain, Czechia, Sweden and 7 more.

Public procurement

The company is the contractor in 3 public sector contracts, worth USD 60.65k in total. They were signed with 3 public buyers.

SubjectAmount
Repair
$734.05
Provision of medical services to ensure the provision of haemodialysis to the contracting party.
$24,797
Acute haemodialysis
$35,116

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2008. In 2026 it is performing 63 contracts with a total value of USD 166.69m. All its contracts were worth USD 2.09bn in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Separately contracted healthcare servicesmałopolskie1USD 25.50m
Separately contracted healthcare serviceswielkopolskie1USD 23.95m
Separately contracted healthcare servicesmazowieckie1USD 18.95m
Separately contracted healthcare servicesśląskie1USD 15.44m
Separately contracted healthcare servicesdolnośląskie1USD 15.08m

NFZ waiting lists

This company's facilities run 263 NFZ waiting lists. Waiting time forecast by NFZ, as of 16.11.2026.

ServiceWaiting time
Outpatient dialysis unitno wait
Outpatient dialysis unitno wait
Outpatient dialysis unitno wait
Outpatient dialysis unitno wait
Outpatient dialysis unitno wait

Job offers

The company has its own careers page: jobs.freseniusmedicalcare.com.

Authorized Representatives

Martyna Dominika Kierzka age 49 – Attorney-in-fact (joint)
Jakub Jan Janiak age 44 – Management Board Member
Mariusz Krzysztof Młodzikowski age 54 – Attorney-in-fact (joint)
Michał Łyskawa age 44 – Management Board Member
Marcin Mariak age 50 – President of the Management Board

Manner of representation

If the management board is a one-person management board, the sole member of the management board represents the company independently. If the management board is a multi-member management board, the company may be represented by two members of the management board jointly, or by one member of the management board jointly with one commercial proxy.

Ownership

OwnerSharesShare valueStake
271,704$36,696,920.58100%

Beneficial owners

Person

Capital group

The company belongs to the Fresenius Medical Care AG (Germany) group, which is its direct owner. The group has 70 companies, 66 of them abroad.

NameCountry
Fresenius Medical Care PolskaPoland
Fresenius Medical Care SscPoland
Biocare Technology Company LimitedHong Kong SAR China
FMC Finance II S.A R.L.Luxembourg
Fresenius Management Services, Inc.United States

Bank accounts

Registered as a VAT taxpayer on 2002-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$2.2M
Buildings and premises
$9.8M

MSiG notices

Publication dateEvent
Aug 9, 2013Commercial Companies Code notice
Jul 11, 2013Commercial Companies Code notice
Sep 14, 2010Commercial Companies Code notice
Sep 14, 2010Commercial Companies Code notice
Jun 10, 2010Merger plan

Public aid

No public aid cases recorded in the last 10 years.

European Funds

ProjectEU co-financing
Disease won't wait, so don't you wait either – developing cancer prevention focused on detecting colorectal cancer in Powiat Łobeski by NZOZ INTERMED Sp. z o.o.
$482.9K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Davita sp. z o.o.

Change history

DateEvent
2013-07-01Share capital increase
2012-04-27Share capital reduction
2010-02-18Share capital increase
2008-10-30Share capital increase
2008-04-28Share capital increase

FAQ

Last updated: 2026-10-07